| __timestamp | Blueprint Medicines Corporation | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 8393000000 |
| Thursday, January 1, 2015 | 48588000 | 7690000000 |
| Friday, January 1, 2016 | 81131000 | 7872000000 |
| Sunday, January 1, 2017 | 144687000 | 7657000000 |
| Monday, January 1, 2018 | 243621000 | 8006000000 |
| Tuesday, January 1, 2019 | 331450000 | 8650000000 |
| Wednesday, January 1, 2020 | 326860000 | 9405000000 |
| Friday, January 1, 2021 | 601033000 | 13829000000 |
| Saturday, January 1, 2022 | 477419000 | 11428000000 |
| Sunday, January 1, 2023 | 427720000 | 10679000000 |
| Monday, January 1, 2024 | 341433000 | 10930000000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Pfizer Inc. and Blueprint Medicines Corporation have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Pfizer's R&D expenses have consistently dwarfed those of Blueprint Medicines, with Pfizer investing nearly 40 times more on average. In 2021, Pfizer's R&D spending peaked at approximately $13.8 billion, a 44% increase from 2014, reflecting its aggressive pursuit of new therapies and vaccines. Meanwhile, Blueprint Medicines, a smaller biotech firm, has shown a remarkable growth trajectory, increasing its R&D spending by over 1,200% during the same period. This stark contrast highlights the diverse strategies within the industry, where established giants and nimble innovators both play crucial roles in advancing medical science.
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Pfizer Inc. vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Comparing Innovation Spending: Pfizer Inc. and Corcept Therapeutics Incorporated
R&D Insights: How Pfizer Inc. and Rhythm Pharmaceuticals, Inc. Allocate Funds
Pfizer Inc. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Viridian Therapeutics, Inc.
R&D Spending Showdown: Gilead Sciences, Inc. vs Blueprint Medicines Corporation
Alnylam Pharmaceuticals, Inc. vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
Blueprint Medicines Corporation or Grifols, S.A.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and ImmunityBio, Inc.
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Blueprint Medicines Corporation and Mesoblast Limited